, Volume 77, Issue 3, p 295

The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) Trial in Postmenopausal Women with Early Breast Cancer – Updated Efficacy Results Based on a Median Follow-up of 47 Months

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access